147 related articles for article (PubMed ID: 27799161)
1. Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice.
Soheili T; Rivière J; Ricciardelli I; Durand A; Verhoeyen E; Derrien AC; Lagresle-Peyrou C; de Saint Basile G; Cosset FL; Amrolia P; André-Schmutz I; Cavazzana M
Blood; 2016 Dec; 128(24):2859-2862. PubMed ID: 27799161
[No Abstract] [Full Text] [Related]
2. Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.
Alosaimi MF; Hoenig M; Jaber F; Platt CD; Jones J; Wallace J; Debatin KM; Schulz A; Jacobsen E; Möller P; Shamseldin HE; Abdulwahab F; Ibrahim N; Alardati H; Almuhizi F; Abosoudah IF; Basha TA; Chou J; Alkuraya FS; Geha RS
J Allergy Clin Immunol; 2019 Aug; 144(2):574-583.e5. PubMed ID: 30872117
[TBL] [Abstract][Full Text] [Related]
3. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.
Wang Z; Kimura S; Iwasaki H; Takase K; Oshiro Y; Gamachi A; Makihara K; Ogata M; Daa T; Momosaki S; Takamatsu Y; Takeshita M
Diagn Pathol; 2021 Jun; 16(1):48. PubMed ID: 34088321
[TBL] [Abstract][Full Text] [Related]
6. Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection.
Lee WI; Lin JJ; Hsieh MY; Lin SJ; Jaing TH; Chen SH; Hung IJ; Yang CP; Chen CJ; Huang YC; Li SP; Huang JL
PLoS One; 2013; 8(10):e76711. PubMed ID: 24204658
[TBL] [Abstract][Full Text] [Related]
7. Fulminant Epstein-Barr virus-driven CD8 positive T-cell lymphoproliferative disorder with chromosomal abnormality.
Tanoshima R; Goto H; Kato H; Yokosuka T; Kajiwara R; Yokota S
Pediatr Blood Cancer; 2011 Jul; 57(1):182. PubMed ID: 21445947
[No Abstract] [Full Text] [Related]
8. The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease.
Patton JT; Lustberg ME; Lozanski G; Garman SL; Towns WH; Drohan CM; Lehman A; Zhang X; Bolon B; Pan L; Kinghorn AD; Grever MR; Lucas DM; Baiocchi RA
Oncotarget; 2015 Feb; 6(5):2693-708. PubMed ID: 25393910
[TBL] [Abstract][Full Text] [Related]
9. Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.
Alkhairy OK; Perez-Becker R; Driessen GJ; Abolhassani H; van Montfrans J; Borte S; Choo S; Wang N; Tesselaar K; Fang M; Bienemann K; Boztug K; Daneva A; Mechinaud F; Wiesel T; Becker C; Dückers G; Siepermann K; van Zelm MC; Rezaei N; van der Burg M; Aghamohammadi A; Seidel MG; Niehues T; Hammarström L
J Allergy Clin Immunol; 2015 Sep; 136(3):703-712.e10. PubMed ID: 25843314
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases].
Kuzushima K
Rinsho Ketsueki; 2000 Jun; 41(6):487-90. PubMed ID: 10921347
[No Abstract] [Full Text] [Related]
11. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
[TBL] [Abstract][Full Text] [Related]
12. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
Smith MC; Cohen DN; Greig B; Yenamandra A; Vnencak-Jones C; Thompson MA; Kim AS
Int J Clin Exp Pathol; 2014; 7(9):5738-49. PubMed ID: 25337215
[TBL] [Abstract][Full Text] [Related]
13. [Systemic EBV+ T-cell lymphoproliferative disease of childhood].
Lemaire AS; Daussay D; Bouchindhomme B; Grardel N; Botte A; Copin MC
Ann Pathol; 2014 Aug; 34(4):339-43. PubMed ID: 25132446
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
[TBL] [Abstract][Full Text] [Related]
15. TEN-like eruption in setting of EBV positive T-cell lymphoproliferative disease with HLH, in a child.
Sharma N; Clark J; Pham H; Efron D; MacGregor D; O'Keefe R; Orchard D
Australas J Dermatol; 2014 Aug; 55(3):e44-7. PubMed ID: 23573996
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
17. Control of Epstein-Barr virus load and lymphoproliferative disease by maintenance of CD8+ T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation.
Torre-Cisneros J; Román J; Torres A; Herrera C; Caston JJ; Rivero A; Mingot E; Rojas R; Martín C; Martínez F; Gómez P
J Infect Dis; 2004 Nov; 190(9):1596-9. PubMed ID: 15478063
[TBL] [Abstract][Full Text] [Related]
18. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
Satou A; Tabata T; Suzuki Y; Sato Y; Tahara I; Mochizuki K; Oishi N; Takahara T; Yoshino T; Tsuzuki T; Nakamura S
Virchows Arch; 2021 May; 478(5):969-976. PubMed ID: 33169195
[TBL] [Abstract][Full Text] [Related]
19. The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection.
Mautner J; Bornkamm GW
Eur J Cell Biol; 2012 Jan; 91(1):31-5. PubMed ID: 21458882
[TBL] [Abstract][Full Text] [Related]
20. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice.
Sato K; Misawa N; Nie C; Satou Y; Iwakiri D; Matsuoka M; Takahashi R; Kuzushima K; Ito M; Takada K; Koyanagi Y
Blood; 2011 May; 117(21):5663-73. PubMed ID: 21467545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
